{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:55:24Z","timestamp":1773100524693,"version":"3.50.1"},"reference-count":22,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/01306"],"award-info":[{"award-number":["PI16\/01306"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01453"],"award-info":[{"award-number":["PI19\/01453"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0016\/0009"],"award-info":[{"award-number":["RD16\/0016\/0009"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP15\/00132"],"award-info":[{"award-number":["CP15\/00132"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>The stimulation of the immune response to prevent the progression of an infection may be an adjuvant to antimicrobial treatment. Here, we aimed to evaluate the efficacy of lysophosphatidylcholine (LPC) treatment in combination with colistin in murine experimental models of severe infections by Acinetobacter baumannii. We used the A. baumannii Ab9 strain, susceptible to colistin and most of the antibiotics used in clinical settings, and the A. baumannii Ab186 strain, susceptible to colistin but presenting a multidrug-resistant (MDR) pattern. The therapeutic efficacies of one and two LPC doses (25 mg\/kg\/d) and colistin (20 mg\/kg\/8 h), alone or in combination, were assessed against Ab9 and Ab186 in murine peritoneal sepsis and pneumonia models. One and two LPC doses combined with colistin and colistin monotherapy enhanced Ab9 and Ab186 clearance from spleen, lungs and blood and reduced mice mortality compared with those of the non-treated mice group in both experimental models. Moreover, one and two LPC doses reduced the bacterial concentration in tissues and blood in both models and increased mice survival in the peritoneal sepsis model for both strains compared with those of the colistin monotherapy group. LPC used as an adjuvant of colistin treatment may be helpful to reduce the severity and the resolution of the MDR A. baumannii infection.<\/jats:p>","DOI":"10.3390\/antibiotics10020194","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T21:35:42Z","timestamp":1613597742000},"page":"194","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against Acinetobacter baumannii in Murine Severe Infections Models"],"prefix":"10.3390","volume":"10","author":[{"given":"Andrea","family":"Mir\u00f3-Canturri","sequence":"first","affiliation":[{"name":"Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, University Hospital Virgen del Roc\u00edo, 41013 Seville, Spain"},{"name":"Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Roc\u00edo, CSIC, University of Seville, 41013 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Ayerbe-Algaba","sequence":"additional","affiliation":[{"name":"Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, University Hospital Virgen del Roc\u00edo, 41013 Seville, Spain"},{"name":"Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Roc\u00edo, CSIC, University of Seville, 41013 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Enrique","family":"Jim\u00e9nez-Mej\u00edas","sequence":"additional","affiliation":[{"name":"Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, University Hospital Virgen del Roc\u00edo, 41013 Seville, Spain"},{"name":"Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Roc\u00edo, CSIC, University of Seville, 41013 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8166-5308","authenticated-orcid":false,"given":"Jer\u00f3nimo","family":"Pach\u00f3n","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Roc\u00edo, CSIC, University of Seville, 41013 Seville, Spain"},{"name":"Department of Medicine, University of Seville, 41009 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9302-8384","authenticated-orcid":false,"given":"Younes","family":"Smani","sequence":"additional","affiliation":[{"name":"Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, University Hospital Virgen del Roc\u00edo, 41013 Seville, Spain"},{"name":"Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Roc\u00edo, CSIC, University of Seville, 41013 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ijantimicag.2019.02.016","article-title":"Multidrug-resistant Acinetobacter baumannii infections: Current evidence on treatment options and the role of pharmacokinetics\/pharmacodynamics in dose optimisation","volume":"53","author":"Sime","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","article-title":"Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: An open-label, randomised controlled trial","volume":"18","author":"Paul","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1128\/IAI.00683-08","article-title":"Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine","volume":"76","author":"Mesquita","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1073\/pnas.85.8.2805","article-title":"Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis","volume":"85","author":"Quinn","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"27346","DOI":"10.1074\/jbc.271.44.27346","article-title":"The scavenger receptor serves as a route for internalization of lysophosphatidylcholine in oxidized low density lipoprotein-induced macrophage proliferation","volume":"271","author":"Sakai","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(03)00422-7","article-title":"Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal","volume":"113","author":"Lauber","year":"2003","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1128\/AAC.04986-14","article-title":"Therapeutic efficacy of lysophosphatidylcholine in severe infections caused by Acinetobacter baumannii","volume":"59","author":"Smani","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1128\/AAC.02708-15","article-title":"Efficacy of lysophosphatidylcholine in combination with antimicrobial agents against Acinetobacter baumannii in experimental murine peritoneal sepsis and pneumonia models","volume":"60","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Parra-Mill\u00e1n, R., Jim\u00e9nez-Mej\u00edas, M.E., Ayerbe-Algaba, R., Dom\u00ednguez-Herrera, J., D\u00edaz, C., P\u00e9rez Del Palacio, J., Pach\u00f3n, J., and Smani, Y. (2020). Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy. Enferm. Infecc. Microbiol. Clin., in press.","DOI":"10.20944\/preprints202002.0171.v1"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e01337-20","DOI":"10.1128\/AAC.01337-20","article-title":"Lysophosphatidylcholine potentiates antibacterial activity of polymexin B","volume":"64","author":"Yadav","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_11","first-page":"4","article-title":"In vitro activity of 18 antimicrobial agents against clinical isolates of Acinetobacter spp.: Multicenter national study GEIH-REIPI-Ab 2010","volume":"31","author":"Bou","year":"2013","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"ref_12","unstructured":"National Research Council (2011). Guide for the Care and Use of Laboratory Animals."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/374337","article-title":"Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: A comparison with imipenem-susceptible VAP","volume":"36","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clinthera.2008.01.015","article-title":"Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, Gram negative bacilli infections: A prospective, open-label, uncontrolled study","volume":"30","author":"Markou","year":"2008","journal-title":"Clin. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/infdis\/jiq159","article-title":"Rifampin protects human lung epithelial cells against cytotoxicity induced by clinical multi and pandrug-resistant Acinetobacter baumannii","volume":"203","author":"Smani","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.micpath.2011.01.008","article-title":"Acinetobacter baumannii-induced lung cell death: Role of inflammation, oxidative stress and cytosolic calcium","volume":"50","author":"Smani","year":"2011","journal-title":"Microb. Pathog."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fimmu.2017.00441","article-title":"The immune response against Acinetobacter baumannii, an emerging pathogen in nosocomial infections","volume":"8","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1128\/IAI.00762-07","article-title":"Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice","volume":"75","author":"KuoLee","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/IAI.00069-11","article-title":"Innate immune responses to systemic Acinetobacter baumannii infection in mice: Neutrophils, but not interleukin-17, mediate host resistance","volume":"79","author":"Breslow","year":"2011","journal-title":"Infect. Immun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nm989","article-title":"Therapeutic effects of lysophosphatidylcholine in experimental sepsis","volume":"10","author":"Yan","year":"2004","journal-title":"Nat. Med."},{"key":"ref_21","first-page":"89","article-title":"Antimicrobial effects of lysophophatidylcholine on methicillin-resistant Staphylococcus aureus","volume":"4","author":"Miyazaki","year":"2017","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/2\/194\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:25:22Z","timestamp":1760160322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/2\/194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["antibiotics10020194"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics10020194","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.12.02.409243","asserted-by":"object"}]},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]}}}